• HOME
  • CES 2027
    • COMING SOON
  • INDUSTRY NEWS & TRENDS
  • EXPERT SPEAK
  • AI
  • IN DEPTH
  • GCC
  • OTHER NEWS
  • EVENTS
    • EVENT CALENDER
    • CANNES LIONS 2026
logo
logo
  • HOME
  • CES 2027
    • COMING SOON
  • INDUSTRY NEWS & TRENDS
  • EXPERT SPEAK
  • AI
  • IN DEPTH
  • GCC
  • OTHER NEWS
  • EVENTS
    • EVENT CALENDER
    • CANNES LIONS 2026

Date-wise News

  • Home
  • Date-wise News
Vogue US Faces Backlash Over Guess Ad ft. AI-Generated Model

  Vogue US Faces Backlash Over Guess Ad Featuring AI-Generated Model

  • by Martech Desk
  • Aug 4, 2025

Vogue faces backlash for using AI-generated model in Guess ad, raising ethical concerns about transparency, job loss, and authenticity in fashion.

OpenAI Secures $8.3 Billion Funding

  OpenAI Secures $8.3 Billion Funding, Propels Valuation to $300 Billion

  • by Martech Desk
  • Aug 4, 2025

OpenAI raises $8.3 billion, boosting its valuation to $300 billion ahead of GPT-5 launch, signaling strong investor confidence in generative AI.

Apple Reportedly Building AI-Powered Search Experience

  Apple Reportedly Building AI-Powered Search Experience with Secret ‘Answers’ Team

  • by Martech Desk
  • Aug 4, 2025

Apple is developing a ChatGPT-style AI search tool via a secret 'Answers' team, aiming to build a native alternative to Google Search within its ecosystem.

Capgemini India to Hire 45,000 Professionals using AI-Ready Talent

  Capgemini India to Hire 45,000 Professionals in 2025, Prioritising AI-Ready Talent

  • by Martech Desk
  • Aug 4, 2025

Capgemini India plans to hire 45,000 professionals in 2025, prioritising AI talent, tier-2 city expansion, and large-scale upskilling initiatives.

OpenAI’s Access to Claude AI Banned by Anthropic

  OpenAI’s Access to Claude AI Cut Off by Anthropic Ahead of GPT-5 Launch

  • by Martech Desk
  • Aug 4, 2025

Amid GPT-5 rollout, Anthropic blocks OpenAI’s access to Claude AI tools over concerns of potential usage during model training. Tensions rise in the competitive AI development space.

Russia starts trials of Personalized mRNA Cancer Vaccine

  Russia Begins Human Trials for Personalized mRNA Cancer Vaccine: An Oncology Breakthrough

  • by Martech Desk
  • Aug 4, 2025

Russia begins human trials for a personalized mRNA cancer vaccine developed by the Gamaleya Center, aiming to transform cancer treatment through patient-specific immunotherapy.

Newsletter

Subscribe for our daily news


Popular Posts

  • Cegeka Names Kim De Maeseneer Chief AI Officer to Lead Global AI Strategy

    • Oct 21,2026
  • Atlys Appoints Rahul Mishra as Head of Growth, Bringing Experience From Housing.com

    • Oct 20,2026
  • PhonePe Rebrands Share.Market as PhonePe Invest, Introduces AI-Powered Portfolio Tool

    • Oct 20,2026
  • Is AI Making Your Ad More Personal Than You Want?

    • Oct 20,2026
  • India's AI Growth Will Need Nuclear Energy, Says Jitendra Singh

    • Oct 21,2026

About Martech News

India’s definitive source for marketing technology news, insights, and trends. Stay ahead with the latest in AI, product strategy, and innovation shaping the future of marketing.

Useful Links

  • Industry News & Trends
  • Expert Speak
  • Latest News
  • Videos
  • Authors

Other Links

  • Privacy Policy
  • Events

CONNECT WITH US

Subscribe to the latest news from MartechAI.com